Recruiting
Phase 2

A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

Sponsor:

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Code:

NCT04814108

Conditions

Uterine Serous Carcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ZN-c3

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information